PURPOSE: To summarize observational studies that focus on the use of glaucoma
medications and to identify gaps in knowledge to guide future investigation. DESIGN …

Purpose The interest in cross-organizational Health Information Exchange (HIE) is
increasing at regional, national and cross-European levels. The purpose of our study was to …

Introduction Fixed-combination intraocular pressure (IOP)—lowering medications simplify
treatment regimens for patients requiring 2 ocular hypotensive agents to maintain sufficiently …

Purpose To analyze patterns of use of adjunctive therapies among new initiators of topical
prostaglandin analogs (PGAs) in a managed care population. Methods The study cohort …

Purpose: To investigate the use of topical ocular anti-glaucoma medications by
glaucomatous patients with obstructive pulmonary disease and their effect on related …

Introduction Few studies have examined outcomes and potential complications among
glaucoma patients who are prescribed topical beta-blockers. This study examined resource …

Purpose: To determine the frequency and economic impact of changing initial glaucoma
therapy for patients with newly diagnosed open-angle glaucoma (OAG) or ocular …

Background Topical β-blockers are commonly prescribed for primary open-angle glaucoma.
Existing research is limited regarding respiratory or cardiovascular events that may result …

The National Committee for Quality Assurance 2006 State of Health Care Quality Report
states that more than 70 million Americans enrolled in private health plans believe the …

Neuere Therapiekonzepte beim Glaukom haben in den letzten Jahren sichtbar nur im
chirurgischen Bereich stattgefunden. Dort kommt ein neuer Stent nach dem anderen auf den …